Background Irritable bowel syndrome (IBS) is a chronic functional bowel disorder.
Disturbances in the gastrointestinal microbiome may be involved in its aetiology. Aim To …

Antibiotics are lifesaving therapeutic drugs that have been used by human for decades.
They are used both in the fight against bacterial pathogens for both human and for animal …

Small intestinal bacterial overgrowth is defined as the presence of excessive numbers of
bacteria in the small bowel, causing gastrointestinal symptoms. This guideline statement …

Irritable bowel syndrome (IBS) is the most prevalent of the functional gastrointestinal
disorders (FGIDs). Current estimates are that IBS affects up to 10–12% of adults in North …

Small intestinal bacterial overgrowth (SIBO) is a common, yet underrecognized, problem. Its
prevalence is unknown because SIBO requires diagnostic testing. Although abdominal …

Irritable bowel syndrome (IBS) is an extremely common and often very debilitating chronic
functional gastrointestinal disorder. Despite its prevalence, significant associated healthcare …

Small intestinal bacterial overgrowth (SIBO) has been implicated in symptoms associated
with functional gastrointestinal disorders (FGIDs), though mechanisms remain poorly …

METHODS: Electronic databases were searched up to December 2018 for studies reporting
SIBO prevalence in patients with IBS. Prevalence rates, odds ratios (ORs), and 95 …

The human body is home to a variety of micro-organisms. Most of these microbial
communities reside in the gut and are referred to as gut microbiota. Over the last decades …

The pathogenesis of irritable bowel syndrome (IBS), once thought to be largely psychogenic
in origin, is now understood to be multifactorial. One of the reasons for this paradigm shift is …